Solutions · Research partners
Study how patients actually reach cancer care.
HMT's registry follows patients from the first finding, through the clinical decision, to the outcome, across the health systems they pass through.
The opportunity
Prospective by construction.
Retrospective registries are assembled after the fact, usually at a single institution. Because HMT's software meets the patient at the moment a finding is made, the record is prospective from the start.
That opens questions that are hard to answer today: how long patients wait between a concerning finding and a specialist, where they are lost, and what happens to patients with rare cancers such as appendiceal and low-grade mucinous tumors.
How we collaborate
Rigorous, and privacy-first.
- Studies are designed with clinical investigators and run under IRB oversight and written data agreements.
- Identifiers are cleared before a record is admitted to the registry.
- We aim to share results through peer-reviewed publication.